Takeda Pharmaceutical (TAK) Long-Term Investments: 2018-2025

  • Takeda Pharmaceutical's Long-Term Investments rose 0.09% to $2.3 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $2.3 billion, marking a year-over-year increase of 0.09%. This contributed to the annual value of $2.3 billion for FY2025, which is 2.45% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Long-Term Investments of $2.3 billion as of Q1 2025, which was up 0.09% from $2.3 billion recorded in Q1 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Long-Term Investments peaked at $2.3 billion during Q1 2025, and registered a low of $2.0 billion during Q1 2022.
  • In the last 3 years, Takeda Pharmaceutical's Long-Term Investments had a median value of $2.3 billion in 2024 and averaged $2.2 billion.
  • Per our database at Business Quant, Takeda Pharmaceutical's Long-Term Investments fell by 9.82% in 2022 and then climbed by 8.75% in 2024.
  • Quarterly analysis of 5 years shows Takeda Pharmaceutical's Long-Term Investments stood at $2.2 billion in 2021, then fell by 9.82% to $2.0 billion in 2022, then rose by 5.21% to $2.1 billion in 2023, then grew by 8.75% to $2.3 billion in 2024, then increased by 0.09% to $2.3 billion in 2025.
  • Its Long-Term Investments stands at $2.3 billion for Q1 2025, versus $2.3 billion for Q1 2024 and $2.1 billion for Q1 2023.